Chopra Nagesh, Amin Anish K, Gupta Anand, Fu Eugene Y, Nichols Allan J, Nelson Steven D, Kleman James M, Kleman James M, Kidwell Gregory A, Billakanty Sreedhar R
Section of Cardiac Electrophysiology, Department of Cardiology, OhioHealth Heart and Vascular Physicians, Riverside Methodist Hospital, 3535 Olentangy River Road, Columbus, OH 43214, USA.
OhioHealth Research and Innovation Institute (OHRI), 3545 Olentangy River Road, Suite 310, Columbus, OH 43214, USA.
J Atr Fibrillation. 2018 Dec 31;11(4):2093. doi: 10.4022/jafib.2093. eCollection 2018 Dec.
Radio-Frequency ablation (RFA) to achieve pulmonary vein isolation (PVI) remains mainstay therapy for symptomatic paroxysmal atrial fibrillation (PAF). The clinical consequences of large saline infusions during AF ablation have not been systematically studied. We utilized the differential flow-rates of the two commercially available ablation catheters (AC): 'ThermoCool' (TCAC) and 'Surround Flow' (SFAC) from Biosense-Webster to evaluate the clinical impact of the saline infused in the immediate post-ablation period.
Consecutive charts of PAF patients between 18 and 81 years who underwent RFA procedure at a tertiary care hospital were reviewed.
Forty-seven patients were included in the study (33Males, 65±11years, LVEF 58±7% and left atrial diameter 44±7.5mm, 23TCAC-use). The saline volume infused through the AC was significantly higher with TCAC vs SFAC use (1277±316vs697±299 ml; p<0.001), with no difference in volume infused from other sources, total procedure or RFA times (p>0.05). This led to significant increase in post-ablation weight gain (96±23 vs 97.5±24kg; p=0.002), furosemide usage (39% vs 0%; p=0.0006), urine production (120±79 vs 63±31ml/hr; p=0.003) and post-RFA potassium reduction (4.4±0.42 vs 4±0.32mmol/l; p<0.001) with TCAC use. Significant post-RFA reduction in magnesium, calcium and creatinine, associated hyperchloremic metabolic acidosis and a modest QTc prolongation were also observed with use of both ACs albeit only moderate to weakly correlated with saline volume infused through the AC. No clinical adverse outcomes were encountered.
Higher saline-volume infusing AC use in PAF ablation causes significant post-ablation weight gain despite higher furosemide use, larger urine production and associated post-RFA potassium reduction without increasing morbidity in lower acuity patients. Furthermore, an array of post-ablation electrolyte disturbances causes a modest and clinically insignificant QTc prolongation.
通过射频消融(RFA)实现肺静脉隔离(PVI)仍然是症状性阵发性心房颤动(PAF)的主要治疗方法。房颤消融期间大量输注生理盐水的临床后果尚未得到系统研究。我们利用Biosense-Webster公司两种市售消融导管(AC)“ThermoCool”(TCAC)和“Surround Flow”(SFAC)的不同流速,评估消融后即刻输注生理盐水的临床影响。
回顾了在一家三级护理医院接受RFA手术的18至81岁PAF患者的连续病历。
47例患者纳入研究(男性33例,65±11岁,左心室射血分数58±7%,左心房直径44±7.5mm,23例使用TCAC)。与使用SFAC相比,使用TCAC时通过AC输注的生理盐水量显著更高(1277±316 vs 697±299 ml;p<0.001),来自其他来源的输液量、总手术时间或RFA时间无差异(p>0.05)。这导致使用TCAC时消融后体重显著增加(96±23 vs 97.5±24kg;p=0.002)、速尿使用增加(39% vs 0%;p=0.0006)、尿量增加(120±79 vs 63±31ml/小时;p=0.003)以及消融后血钾降低(4.4±0.42 vs 4±0.32mmol/l;p<0.001)。使用两种AC时均观察到消融后镁、钙和肌酐显著降低,伴有高氯性代谢性酸中毒以及QTc适度延长,尽管仅与通过AC输注的生理盐水量呈中度至弱相关。未遇到临床不良结局。
在PAF消融中使用更高生理盐水输注量的AC会导致消融后体重显著增加,尽管速尿使用增加、尿量增多以及消融后血钾降低,但在低危患者中并未增加发病率。此外,一系列消融后电解质紊乱导致QTc适度延长,但在临床上无显著意义。